Materials and methods for detecting cancer based on urinary levels of RHAMM
AssigneeUniversity of South Florida
InventorsPatricia Ann Kruk, Stephanie Tania Buttermore
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of South Florida
InventorsPatricia Ann Kruk, Stephanie Tania Buttermore
Estimating the term…
The invention pertains to diagnosis and treatment of ovarian cancer (OC), cervical cancer (CC), or colorectal cancer (CRC). One embodiment of the invention provides a method of identifying OC, CC, or CRC based on the level of RHAMM in the urine of a subject. Another embodiment of the invention provides a method of identifying OC based on the level of RHAMM in the urine and CA125 in the blood of a subject. The invention also pertains to monitoring the efficacy of a treatment of OC, CC, or CRC based on the level of RHAMM protein in the urine and/or the level of CA125 in the blood. Another embodiment of the invention provides devices and reagents to assay RHAMM in a urine sample and optionally, assay CA125 in a blood sample.
A kit for assaying RHAMM level and CA125 level, the kit consisting essentially of:
Dependencies are inferred from the claim text.